Home > Cashflow Statement > AJANTA PHARMA

AJANTA PHARMA
Cashflow Statement

AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Profit Before Tax₹1,378 Cr₹1,189 Cr₹1,114 Cr₹745 Cr₹909 Cr
Adjustment ₹163 Cr₹112 Cr₹83 Cr₹131 Cr₹92 Cr
Changes In working Capital ₹-653 Cr₹179 Cr₹-100 Cr₹67 Cr₹-200 Cr
Cash Flow after changes in Working Capital ₹888 Cr₹1,480 Cr₹1,097 Cr₹943 Cr₹801 Cr
Cash Flow from Operating Activities ₹529 Cr₹1,157 Cr₹785 Cr₹792 Cr₹562 Cr
Cash Flow from Investing Activities ₹-429 Cr₹-377 Cr₹65 Cr₹-560 Cr₹-74 Cr
Cash Flow from Financing Activities ₹-168 Cr₹-733 Cr₹-1,051 Cr₹-108 Cr₹-460 Cr
Net Cash Inflow / Outflow ₹-68 Cr₹47 Cr₹-201 Cr₹124 Cr₹28 Cr
Opening Cash & Cash Equivalents ₹175 Cr₹129 Cr₹330 Cr₹206 Cr₹178 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹107 Cr₹177 Cr₹129 Cr₹331 Cr₹205 Cr

Compare Cashflow Statement of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹43,935.6 Cr 5.4% 5.7% 24.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,870.0 Cr -1.4% 2.4% 17.1% Stock Analytics
DIVIS LABORATORIES ₹220,946.0 Cr 12.2% 23.1% 21.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,907.0 Cr 2.4% 5.3% 41.7% Stock Analytics
CIPLA ₹118,674.0 Cr 1.7% 0.7% -3.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,648.7 Cr 3% -14.9% -10.2% Stock Analytics


AJANTA PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

5.4%

5.7%

24.8%

SENSEX

2.4%

1.5%

-4.3%


You may also like the below Video Courses